| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |